Conditions: Metastatic Malignant Neoplasm in the Lung; Metastatic Osteosarcoma; Recurrent Osteosarcoma Interventions: Biological: Dinutuximab; Other: Laboratory Biomarker Analysis; Other: Pharmacological Study; Biological: Sargramostim
Principal Investigator:
Shen, Violet
Research Coordinator:
Kathryn Duvall
(714) 509-8646
Visit clinicaltrials.gov for more information about this trial.
- IRB Number: 151298
- Sponsor: COG
- Protocol Number: AOST1421
- NCT Number: NCT02484443
- Research Type: Recurrent/Refractory Cancer, Solid Tumors
- Phase: II
- Status: Active - Open to Enrollment
